These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27106876)

  • 41. Synthesis and anticancer properties of ruthenium (II) complexes as potent apoptosis inducers through mitochondrial disruption.
    Wan D; Tang B; Wang YJ; Guo BH; Yin H; Yi QY; Liu YJ
    Eur J Med Chem; 2017 Oct; 139():180-190. PubMed ID: 28800456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Defining the Anti-Cancer Activity of Tricarbonyl Rhenium Complexes: Induction of G2/M Cell Cycle Arrest and Blockade of Aurora-A Kinase Phosphorylation.
    Simpson PV; Casari I; Paternoster S; Skelton BW; Falasca M; Massi M
    Chemistry; 2017 May; 23(27):6518-6521. PubMed ID: 28337805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells.
    Balakrishna MS; Suresh D; Rai A; Mague JT; Panda D
    Inorg Chem; 2010 Oct; 49(19):8790-801. PubMed ID: 20812680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tautomerization of 2-nitroso-N-arylanilines by coordination as N,N'-chelate ligands to rhenium(I) complexes and the anticancer activity of newly synthesized oximine rhenium(I) complexes against human melanoma and leukemia cells in vitro.
    Wirth S; Wallek AU; Zernickel A; Feil F; Sztiller-Sikorska M; Lesiak-Mieczkowska K; Bräuchle C; Lorenz IP; Czyz M
    J Inorg Biochem; 2010 Jul; 104(7):774-89. PubMed ID: 20421133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis.
    Zhou XQ; Li Y; Zhang DY; Nie Y; Li ZJ; Gu W; Liu X; Tian JL; Yan SP
    Eur J Med Chem; 2016 May; 114():244-56. PubMed ID: 26994692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A phosphorescent rhenium(I) histone deacetylase inhibitor: mitochondrial targeting and paraptosis induction.
    Ye RR; Tan CP; Lin YN; Ji LN; Mao ZW
    Chem Commun (Camb); 2015 May; 51(39):8353-6. PubMed ID: 25882790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tricarbonyl M(I) (M = Re, (99m)Tc) complexes bearing acridine fluorophores: synthesis, characterization, DNA interaction studies and nuclear targeting.
    Esteves T; Xavier C; Gama S; Mendes F; Raposinho PD; Marques F; Paulo A; Pessoa JC; Rino J; Viola G; Santos I
    Org Biomol Chem; 2010 Sep; 8(18):4104-16. PubMed ID: 20648265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity.
    Banerjee S; Chakravarty AR
    Acc Chem Res; 2015 Jul; 48(7):2075-83. PubMed ID: 26158541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, characterization, in vivo antitumor properties of the cluster rhenium compound with GABA ligands and its synergism with cisplatin.
    Shtemenko AV; Collery P; Shtemenko NI; Domasevitch KV; Zabitskaya ED; Golichenko AA
    Dalton Trans; 2009 Jul; (26):5132-6. PubMed ID: 19562173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gold(I)-NHC complexes of antitumoral diarylimidazoles: structures, cellular uptake routes and anticancer activities.
    Kaps L; Biersack B; Müller-Bunz H; Mahal K; Münzner J; Tacke M; Mueller T; Schobert R
    J Inorg Biochem; 2012 Jan; 106(1):52-8. PubMed ID: 22112840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Asymmetric rhenium tricarbonyl complexes show superior luminescence properties in live cell imaging.
    Raszeja LJ; Siegmund D; Cordes AL; Güldenhaupt J; Gerwert K; Hahn S; Metzler-Nolte N
    Chem Commun (Camb); 2017 Jan; 53(5):905-908. PubMed ID: 28008445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overcoming cisplatin resistance using gold(III) mimics: anticancer activity of novel gold(III) polypyridyl complexes.
    Palanichamy K; Sreejayan N; Ontko AC
    J Inorg Biochem; 2012 Jan; 106(1):32-42. PubMed ID: 22112837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents.
    Song XD; Kong X; He SF; Chen JX; Sun J; Chen BB; Zhao JW; Mao ZW
    Eur J Med Chem; 2017 Sep; 138():246-254. PubMed ID: 28668477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Necrosis-Inducing High-Valent Oxo-Rhenium(V) Complexes with Potent Antitumor Activity: Synthesis, Aquation Chemistry, Cisplatin Cross-Resistance Profile, and Mechanism of Action.
    Das S; Joshi P; Patra M
    Inorg Chem; 2023 Dec; 62(48):19720-19733. PubMed ID: 37974075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Triggering autophagic cell death with a di-manganese(II) developmental therapeutic.
    Slator C; Molphy Z; McKee V; Kellett A
    Redox Biol; 2017 Aug; 12():150-161. PubMed ID: 28236767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro and in vivo anticancer effects of singly protonated dehydronorcantharidin silver coordination polymer in CT-26 murine colon carcinoma model.
    Jin X; Tan X; Zhang X; Han M; Zhao Y
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4477-80. PubMed ID: 26346364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phosphorescent rhenium(I) complexes conjugated with artesunate: Mitochondrial targeting and apoptosis-ferroptosis dual induction.
    Ye RR; Chen BC; Lu JJ; Ma XR; Li RT
    J Inorg Biochem; 2021 Oct; 223():111537. PubMed ID: 34273716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design of Rhenium Compounds in Targeted Anticancer Therapeutics.
    Collery P; Desmaele D; Vijaykumar V
    Curr Pharm Des; 2019; 25(31):3306-3322. PubMed ID: 31475892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
    Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
    Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.
    Zhao Z; Luo Z; Wu Q; Zheng W; Feng Y; Chen T
    Dalton Trans; 2014 Dec; 43(45):17017-28. PubMed ID: 25087850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.